Recombinant human erythropoietin therapy in low‐birthweight preterm infants: A prospective controlled study

Abstract

Recombinant erythropoietin is effective therapy for maintaining stable hematocrit levels in low-birthweight preterm infants and prevents the need for blood transfusions.